Today, Latent Labs introduced Latent-Y, an AI agent that can create therapeutic antibodies from a text prompt, drastically reducing the time needed for expert work from weeks to hours. Latent-Y operates using Latent-X2, the cutting-edge model by Latent Labs for designing drug-like antibodies and peptides, democratizing structural drug design for researchers without the need for specialized infrastructure. Latent Labs is granting access to chosen partners for Latent-Y, a tool that amplifies efficiency in drug discovery.